Literature DB >> 507794

Piperacillin susceptibility tests by the single-disk agar diffusion technique.

A L Barry, C Thornsberry, R E Badal, C N Baker, R N Jones, E H Gerlach.   

Abstract

Piperacillin is a new semisynthetic penicillin with a spectrum of activity broader than that of carbenicillin or ticarcillin. Studies were performed to establish standards for agar diffusion susceptibility tests with piperacillin disks. Tests with 100-, 150-, and 200-micrograms piperacillin disks and with 100-micrograms carbenicillin disks were evaluated. With both penicillins, 100-micrograms disks were satisfactory, in spite of the fact that piperacillin is a larger molecule and diffuses at a slower rate. With both carbenicillin and piperacillin disks, resistant strains of Staphylococcus aureus produced zones less than or equal to 28 mm and susceptible strains gave zones greater than or equal to 29 mm in diameter. When testing other microorganisms, zone standards of less than or equal to 13 mm for resistant (minimal inhibitory concentration, greater than or equal to 256 micrograms/ml) and greater than or equal to 17 mm for susceptible (minimal inhibitory concentration, less than or equal to 64 micrograms/ml) are recommended for tests with 100-micrograms piperacillin disks. Similar zone standards are currently recommended for carbenicillin and ticarcillin disk tests.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507794      PMCID: PMC352864          DOI: 10.1128/AAC.16.3.378

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.

Authors:  C Thornsberry; C N Baker; R N Jones
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  In vitro and in vivo activity of piperacillin, a new broad-spectrum semisynthetic penicillin.

Authors:  N A Kuck; G S Redin
Journal:  J Antibiot (Tokyo)       Date:  1978-11       Impact factor: 2.649

4.  Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.

Authors:  P C Fuchs; C Thornsberry; A L Barry; T L Gavan; E H Gerlach; R N Jones
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

5.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

7.  Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.

Authors:  M F Parry; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

8.  Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.

Authors:  T B Tjandramaga; A Mullie; R Verbesselt; P J De Schepper; L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

9.  Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.

Authors:  R N Jones; R R Packer; A L Barry; R E Badal; C Thornsberry; C Baker
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

  9 in total
  10 in total

1.  Comparison of efficacy and cost-effectiveness of BIOMIC VIDEO and Vitek antimicrobial susceptibility test systems for use in the clinical microbiology laboratory.

Authors:  I Berke; P M Tierno
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

2.  Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones; T L Gavan
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Evaluation of the BIOGRAM antimicrobial susceptibility test system.

Authors:  R F D'Amato; L Hochstein; J R Vernaleo; D J Cleri; A A Wallman; M S Gradus; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

4.  [Resistance of clinical isolates of some Enterobacteriaceae as well as Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus faecalis to chemotherapeutic agents. Results of an inter-regional cooperative study for the years 1980 and 1981].

Authors:  B Wiedemann
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

5.  Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

7.  Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.

Authors:  M J Gribble; A W Chow; S C Naiman; J A Smith; W R Bowie; S L Sacks; L Grossman; N Buskard; G H Growe; L H Plenderleith
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

9.  Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

10.  Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones; E H Gerlack
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.